H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Go back to H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.14 -0.6 (4.37%)
Previous Close $13.74    52 Week High $34.49 
Open $13.99    52 Week Low $20.39 
Day High $13.99    P/E N/A 
Day Low $12.99    EPS $-3.18 
Volume 112,949